A total of 199 Māori and Pacific participants with T2D at the time of recruitment underwent targeted sequencing, with one individual removed from further analysis having tested positive for the presence of T1D autoantibodies GAD/IA-2/ZnT8 (Figure 1). This evidence concerns the gene GAD1 and type 2 diabetes mellitus.